Deucravacitinib on Rheumatology Digesthttps://rheumatologydigest.org/tags/deucravacitinib/Recent content in Deucravacitinib on Rheumatology DigestHugoen-usSun, 27 Sep 2026 03:00:00 +0530Deucravacitinib in PsA: POETYK PsA-1 at 52 Weekshttps://rheumatologydigest.org/posts/deucravacitinib-poetyk-psa-1/Sun, 27 Sep 2026 03:00:00 +0530https://rheumatologydigest.org/posts/deucravacitinib-poetyk-psa-1/Deucravacitinib beat placebo on joints, skin and function, but the pre-specified X-ray endpoint failed — structural protection rests on post hoc analysis.